Neuregulin and dopamine modulation of hippocampal gamma oscillations is dependent on dopamine D4 receptors

Proceedings of the National Academy of Sciences of the United States of America

Volumn 109, Issue 32, 2012, Pages 13118-13123

  Andersson, Richard H ^a   Johnston, April ^a   Herman, Paul A ^b   Winzer Serhan, Ursula H ^c   Karavanova, Irina ^b   Vullhorst, Detlef ^b   Fisahn, André ^a   Buonanno, Andres ^b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^c TEXAS A AND M UNIVERSITY SYSTEM   (United States)

Author keywords

Attention deficit hyperactivity disorder; Cognitive enhancers; Excitatory inhibitory balance; Fast spiking interneuron

Indexed keywords

3 [[4 (4 CHLOROPHENYL) 1 PIPERAZINYL]METHYL] 1H PYRROLO[2,3 B]PYRIDINE; CLOZAPINE; DOPAMINE; DOPAMINE 1 RECEPTOR STIMULATING AGENT; DOPAMINE 2 RECEPTOR STIMULATING AGENT; DOPAMINE 4 RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 4; GLUTAMATE DECARBOXYLASE 67; MESSENGER RNA; N [4 (2 CYANOPHENYL) 1 PIPERAZINYLMETHYL] 3 METHYLBENZAMIDE; NEU DIFFERENTIATION FACTOR; PARVALBUMIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ATTENTION DISTURBANCE; CONTROLLED STUDY; EXECUTIVE FUNCTION; FLUORESCENCE HISTOCHEMISTRY; GABAERGIC SYSTEM; GENETIC POLYMORPHISM; HIPPOCAMPUS; IMMUNOFLUORESCENCE TEST; IN SITU HYBRIDIZATION; INTERNEURON; MEMORY DISORDER; MOUSE; NEUROMODULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; WORKING MEMORY;

ANIMALS; BRAIN WAVES; DOPAMINE; FLUORESCENT ANTIBODY TECHNIQUE; FOURIER ANALYSIS; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INTERNEURONS; NEUREGULINS; PYRIDINES; PYRROLES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D4; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

EID: 84864700667     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1201011109     Document Type: Article

References (48)

1. Uhlhaas PJ, Singer W (2010) Abnormal neural oscillations and synchrony in schizophrenia. Nat Rev Neurosci 11:100-113.
2. Lewis DA, Fish KN, Arion D, Gonzalez-Burgos G (2011) Perisomatic inhibition and cortical circuit dysfunction in schizophrenia. Curr Opin Neurobiol 21:866-872.
3. Minzenberg MJ, et al. (2010) Gamma oscillatory power is impaired during cognitive control independent of medication status in first-episode schizophrenia. Neuropsychopharmacology 35:2590-2599.
4. Colgin LL, Moser EI (2010) Gamma oscillations in the hippocampus. Physiology (Bethesda) 25:319-329.
5. Whittington MA, Traub RD, Jefferys JG (1995) Synchronized oscillations in interneuron networks driven by metabotropic glutamate receptor activation. Nature 373:612-615.
6. Fisahn A, Pike FG, Buhl EH, Paulsen O (1998) Cholinergic induction of network oscillations at 40 Hz in the hippocampus in vitro. Nature 394:186-189. (Pubitemid 28325972)
7. Hájos N, et al. (2000) Cannabinoids inhibit hippocampal GABAergic transmission and network oscillations. Eur J Neurosci 12:3239-3249.
8. Fisahn A, et al. (2004) Distinct roles for the kainate receptor subunits GluR5 and GluR6 in kainate-induced hippocampal gamma oscillations. J Neurosci 24:9658-9668. (Pubitemid 39441520)
9. Leão RN, Tan HM, Fisahn A (2009) Kv7/KCNQ channels control action potential phasing of pyramidal neurons during hippocampal gamma oscillations in vitro. J Neurosci 29:13353-13364.
10. Bartos M, Vida I, Jonas P (2007) Synaptic mechanisms of synchronized gamma oscillations in inhibitory interneuron networks. Nat Rev Neurosci 8:45-56. (Pubitemid 46011998)
11. Fuchs EC, et al. (2007) Recruitment of parvalbumin-positive interneurons determines hippocampal function and associated behavior. Neuron 53:591-604. (Pubitemid 46216760)
12. Korotkova T, Fuchs EC, Ponomarenko A, von Engelhardt J, Monyer H (2010) NMDA receptor ablation on parvalbumin-positive interneurons impairs hippocampal synchrony, spatial representations, and working memory. Neuron 68:557-569.
13. Sohal VS, Zhang F, Yizhar O, Deisseroth K (2009) Parvalbumin neurons and gamma rhythms enhance cortical circuit performance. Nature 459:698-702.
14. Carlen M, et al. (2011) A critical role for NMDA receptors in parvalbumin interneurons for gamma rhythm induction and behavior. Mol Psychiatry 17:537-548.
15. Winterer G, Weinberger DR (2004) Genes, dopamine and cortical signal-to-noise ratio in schizophrenia. Trends Neurosci 27:683-690. (Pubitemid 39335839)
16. Jay TM (2003) Dopamine: A potential substrate for synaptic plasticity and memory mechanisms. Prog Neurobiol 69:375-390.
17. Buonanno A (2010) The neuregulin signaling pathway and schizophrenia: From genes to synapses and neural circuits. Brain Res Bull 83:122-131.
18. Kwon OB, et al. (2008) Neuregulin-1 regulates LTP at CA1 hippocampal synapses through activation of dopamine D4 receptors. Proc Natl Acad Sci USA 105:15587-15592.
19. Fisahn A, Neddens J, Yan L, Buonanno A (2009) Neuregulin-1 modulates hippocampal gamma oscillations: Implications for schizophrenia. Cereb Cortex 19:612-618.
20. Neddens J, Buonanno A (2010) Selective populations of hippocampal interneurons express ErbB4 and their number and distribution is altered in ErbB4 knockout mice. Hippocampus 20:724-744.
21. Neddens J, et al. (2011) Conserved interneuron-specific ErbB4 expression in frontal cortex of rodents, monkeys, and humans: Implications for schizophrenia. Biol Psychiatry 70:636-645.
22. Trantham-Davidson H, Neely LC, Lavin A, Seamans JK (2004) Mechanisms underlying differential D1 versus D2 dopamine receptor regulation of inhibition in prefrontal cortex. J Neurosci 24:10652-10659. (Pubitemid 39557638)
23. Goto Y, Otani S, Grace AA (2007) The Yin and Yang of dopamine release: A new perspective. Neuropharmacology 53:583-587. (Pubitemid 47516678)
24. Ariano MA, Wang J, Noblett KL, Larson ER, Sibley DR (1997) Cellular distribution of the rat D4 dopamine receptor protein in the CNS using anti-receptor antisera. Brain Res 752:26-34. (Pubitemid 27143894)
25. Mrzljak L, et al. (1996) Localization of dopamine D4 receptors in GABAergic neurons of the primate brain. Nature 381:245-248. (Pubitemid 26148034)
26. Defagot MC, Malchiodi EL, Villar MJ, Antonelli MC (1997) Distribution of D4 dopamine receptor in rat brain with sequence-specific antibodies. Brain Res Mol Brain Res 45:1-12. (Pubitemid 27182219)
27. Bunnett NW, Cottrell GS (2010) Trafficking and signaling of G protein-coupled receptors in the nervous system: implications for disease and therapy. CNS Neurol Disord Drug Targets 9:539-556.
28. Andersson R, Johnston A, Fisahn A (2012) D4 receptor-dependant augmentation of hippocampal gamma oscillations by increased spiking coherence in fast-spiking interneurons. PLoS ONE 7(7):e40906.
29. Weiss T, Veh RW, Heinemann U (2003) Dopamine depresses cholinergic oscillatory network activity in rat hippocampus. Eur J Neurosci 18:2573-2580. (Pubitemid 37452673)
30. Lisman JE, et al. (2008) Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia. Trends Neurosci 31:234-242.
31. Yizhar O, et al. (2011) Neocortical excitation/inhibition balance in information processing and social dysfunction. Nature 477:171-178.
32. Yuen EY, Yan Z (2009) Dopamine D4 receptors regulate AMPA receptor trafficking and glutamatergic transmission in GABAergic interneurons of prefrontal cortex. J Neurosci 29:550-562.
33. Graziane NM, Yuen EY, Yan Z (2009) Dopamine D4 receptors regulate GABAA receptor trafficking via an actin/cofilin/myosin-dependent mechanism. J Biol Chem 284:8329-8336.
34. Greenwood TA, et al. (2011) Analysis of 94 candidate genes and 12 endophenotypes for schizophrenia from the Consortium on the Genetics of Schizophrenia. Am J Psychiatry 168:930-946.
35. DiMaio S, Grizenko N, Joober R (2003) Dopamine genes and attention-deficit hyperactivity disorder: A review. J Psychiatry Neurosci 28:27-38. (Pubitemid 36315349)
36. Demiralp T, et al. (2007) DRD4 and DAT1 polymorphisms modulate human gamma band responses. Cereb Cortex 17:1007-1019. (Pubitemid 46598842)
37. Stefansson H, et al. (2002) Neuregulin 1 and susceptibility to schizophrenia. Am J Hum Genet 71:877-892. (Pubitemid 135750519)
38. Shamir A, et al. (2012) The importance of the NRG-1/ErbB4 pathway for synaptic plasticity and behaviors associated with psychiatric disorders. J Neurosci 32:2988-2997.
39. Arnsten AF, Murphy B, Merchant K (2000) The selective dopamine D4 receptor antagonist, PNU-101387G, prevents stress-induced cognitive deficits in monkeys. Neuropsychopharmacology 23:405-410.
40. Young JW, Powell SB, Scott CN, Zhou X, Geyer MA (2011) The effect of reduced dopamine D4 receptor expression in the 5-choice continuous performance task: Separating response inhibition from premature responding. Behav Brain Res 222:183-192.
41. Insel TR (2010) Rethinking schizophrenia. Nature 468:187-193.
42. Spencer KM (2008) Visual gamma oscillations in schizophrenia: Implications for understanding neural circuitry abnormalities. Clin EEG Neurosci 39:65-68.
43. Herrmann CS, Demiralp T (2005) Human EEG gamma oscillations in neuropsychiatric disorders. Clin Neurophysiol 116:2719-2733. (Pubitemid 41714021)
44. Bristow LJ, et al. (1997) Schizophrenia and L-745,870, a novel dopamine D4 receptor antagonist. Trends Pharmacol Sci 18:186-188. (Pubitemid 27283645)
45. Corrigan MH, Gallen CC, Bonura ML, Merchant KM; Sonepiprazole Study Group (2004) Effectiveness of the selective D4 antagonist sonepiprazole in schizophrenia: A placebo-controlled trial. Biol Psychiatry 55:445-451. (Pubitemid 38338530)
46. Zhang K, et al. (2004) Regulation of working memory by dopamine D4 receptor in rats. Neuropsychopharmacology 29:1648-1655. (Pubitemid 39150106)
47. Braszko JJ (2009) Dopamine D4 receptor antagonist L745,870 abolishes cognitive effects of intracerebroventricular angiotensin IV and des-Phe(6)-Ang IV in rats. Eur Neuropsychopharmacol 19:85-91.
48. Son JH, Winzer-Serhan UH (2009) Signal intensities of radiolabeled cRNA probes used alone or in combination with non-isotopic in situ hybridization histochemistry. J Neurosci Methods 179:159-165.